Tag: Medicare coverage
The Food and Drug Administration recently granted fast-track approval to a new Alzheimer’s drug designed to slow the rate of cognitive decline for individuals in the early stages of the disease. The drug, which will be sold under the brand name Leqembi, was developed jointly by Eisai and Biogen – the same two companies that…
The brief’s key findings are: The Medicare Part D prescription drug program covers a large percentage of the elderly and their prescription costs. Strikingly, as of 2007, about 70 percent of the program’s enrollees already had drug coverage before joining Part D. Similarly, about 75 percent of Part D spending substituted for spending by privat…
